Potent Antitumor Activity of AP24534, an Orally Active Inhibitor of Bcr-Abl Variants Including T315I, in In Vitro and In Vivo Models of Chronic Myeloid Leukemia (CML).

Autor: Rivera, Victor M. *, Xu, Qihong *, Wang, Frank *, Snodgrass, Joseph *, O'Hare, Thomas *, Corbin, Amie S. *, Keats, Jeffrey *, Lamore, Sarah *, Ning, Yaoyu *, Wardwell, Scott *, Russian, Karin *, Broudy, Marc *, Shakespeare, William C. *, Druker, Brian J., Iuliucci, John D. *, Clackson, Tim *
Zdroj: In Blood 16 November 2007 110(11):1032-1032
Databáze: ScienceDirect